All Stories

  1. Efficacy of transdermal rotigotine in chronic cluster headache: A case series
  2. Altered resting-state EEG source functional connectivity in schizophrenia: the effect of illness duration
  3. The use of illicit drugs as self-medication in the treatment of cluster headache: Results from an Italian online survey
  4. Genetics of Headache
  5. Molecular bases of neurophysiologic dysfunctions in migraine
  6. Obesity, diet and nutraceuticals
  7. O017. Cortical functional correlates of responsiveness to short-lasting preventive intervention with ketogenic diet (KD) in migraine: a multimodal evoked potentials study
  8. O024. Transcutaneous supraorbital nerve stimulation enhances somatosensory thalamic activity in migraine between attacks: a central mechanism of clinical efficacy?
  9. O025. Excitability of the motor cortex in migraine changes with the distance from the last attack
  10. Molecular genotype in migraine
  11. O045. Cluster headache improvement during Ketogenic Diet
  12. O060. Rotigotine improves drug-resistant cluster headache: a case series
  13. O041. GRIA3 (glutamate receptor, ionotropic, ampa 3) gene polymorphism influences cortical response to somatosensory stimulation in medication-overuse headache (MOH) patients
  14. O028. Thalamo-cortical network changes during the migraine cycle: insights from MRI-based microstructural and functional resting-state network correlation analysis
  15. O026. An abnormal transduction of the chromatic stimuli from the outer to the inner retinal layers may contribute to cause photophobia in migraine
  16. Evidence for brain morphometric changes during the migraine cycle: A magnetic resonance-based morphometry study
  17. Lateralized nociceptive blink reflex habituation deficit in episodic cluster headache: Correlations with clinical features
  18. Migraine improvement during short lasting ketogenesis: a proof-of-concept study
  19. P906: Central mechanisms of migraine improvement with ketogenic diet
  20. P902: Visual evoked potentials in subgroups of migraine with aura patients
  21. O45: Lateral inhibition in somatosensory cortex of migraine without aura patients between attacks
  22. Poster #M178 VISUAL HABITUATION IS IMPAIRED IN SCHIZOPHRENIA: A STUDY WITH PATTERN REVERSAL VISUAL EVOKED POTENTIALS
  23. Pharmacogenomics of episodic migraine: time has come for a step forward
  24. The upstream Variable Number Tandem Repeat polymorphism of the monoamine oxidase type A gene influences trigeminal pain-related evoked responses
  25. Neuromuscular transmission studied with SFEMG in migraine with aura: phenotypic correlations in 93 patients
  26. Nasal decongestant and chronic headache: a case of naphazoline overuse headache?
  27. Dynamic changes in thalamic microstructure of migraine without aura patients: a diffusion tensor magnetic resonance imaging study
  28. 14. Lateral inhibition in somatosensory cortex of migraine without aura patients between attacks
  29. Rotigotine improves executive functions in patients with vascular dementia
  30. A case of cluster headache treated with rotigotine: Clinical and neurophysiological correlates
  31. Cognitive impairment in primary brain tumors outpatients: a prospective cross-sectional survey
  32. Lateral inhibition in visual cortex of migraine patients between attacks
  33. Habituation and sensitization in primary headaches
  34. Electrophysiological correlates of episodic migraine chronification: evidence for thalamic involvement
  35. Influence of rTMS over the left primary motor cortex on initiation and performance of a simple movement executed with the contralateral arm in healthy volunteers
  36. Epilepsy in the end-of-life phase in patients with high-grade gliomas
  37. Cortical response to somatosensory stimulation in medication overuse headache patients is influenced by angiotensin converting enzyme (ACE) I/D genetic polymorphism
  38. Illicit drug use in cluster headache patients and in the general population: A comparative cross-sectional survey
  39. Migraine headache: a review of the molecular genetics of a common disorder
  40. The Val66Met Polymorphism of the BDNF Gene Influences Trigeminal Pain-Related Evoked Responses
  41. Use of Vitex agnus-castus in migrainous women with premenstrual syndrome: an open-label clinical observation
  42. Quality of Care and Rehospitalization Rate in the Last Stage of Disease in Brain Tumor Patients Assisted at Home: A Cost Effectiveness Study
  43. Drug-induced changes in cortical inhibition in medication overuse headache
  44. S20.3 Impairment visual system short-range lateral inhibition in migraine without aura patients
  45. P23.9 Somatosensory high-frequency oscillations in medication overuse headache
  46. P23.13 Cortical inhibition in chronic headache changes according to the medication overused
  47. Abnormal cortical responses to somatosensory stimulation in medication-overuse headache
  48. Nociceptive trigeminocervical reflexes in healthy subjects
  49. Tonic Pain Abolishes Cortical Habituation of Visual Evoked Potentials in Healthy Subjects
  50. From stargazing chicks to seizing infants: Thiamine deficiency redux
  51. Lack of cold pressor test-induced effect on visual-evoked potentials in migraine
  52. BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson’s disease
  53. Pharmacogenomics and medication overuse headache: when the cure may turn to poison
  54. Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism
  55. Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs
  56. Heat stress disorders and headache: a case of new daily persistent headache secondary to heat stroke
  57. End of life issues in brain tumor patients
  58. End of life issues in brain tumor patients
  59. Use of complementary and alternative medicine by patients with cluster headache: Results of a multi-centre headache clinic survey
  60. Heat stress disorders and headache: a case of new daily persistent headache secondary to heat stroke
  61. The wolframin His611Arg polymorphism influences medication overuse headache
  62. Early-onset progressive ataxia associated with the first CACNA1A mutation identified within the I–II loop
  63. Advice Alone Vs. Structured Detoxification Programmes for Medication Overuse Headache: A Prospective, Randomized, Open-Label Trial in Transformed Migraine Patients With Low Medical Needs
  64. Prevalence, Pattern and Predictors of use of Complementary and Alternative Medicine (CAM) in Migraine Patients Attending a Headache Clinic in Italy
  65. Depressive Symptoms and Insecure Attachment as Predictors of Disability in a Clinical Population of Patients With Episodic and Chronic Migraine
  66. Chronic daily headache: old problems, new vistas
  67. Faculty of 1000 evaluation for Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma.
  68. Faculty of 1000 evaluation for The relationships between depression and brain tumors.
  69. Faculty of 1000 evaluation for Medical decision-making capacity in patients with malignant glioma.
  70. Faculty of 1000 evaluation for PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma.
  71. Faculty of 1000 evaluation for Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma.
  72. Faculty of 1000 evaluation for Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.
  73. Faculty of 1000 evaluation for NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.